GEP20012466B - Lysozyme Dimer and Compositions Containing the Same - Google Patents

Lysozyme Dimer and Compositions Containing the Same

Info

Publication number
GEP20012466B
GEP20012466B GEAP19932466A GEAP1993002466A GEP20012466B GE P20012466 B GEP20012466 B GE P20012466B GE AP19932466 A GEAP19932466 A GE AP19932466A GE AP1993002466 A GEAP1993002466 A GE AP1993002466A GE P20012466 B GEP20012466 B GE P20012466B
Authority
GE
Georgia
Prior art keywords
same
compositions containing
lysozyme dimer
dimer
protective mechanism
Prior art date
Application number
GEAP19932466A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of GEP20012466B publication Critical patent/GEP20012466B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GEAP19932466A 1992-07-13 1993-07-13 Lysozyme Dimer and Compositions Containing the Same GEP20012466B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL92295273A PL173978B1 (pl) 1992-07-13 1992-07-13 Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej

Publications (1)

Publication Number Publication Date
GEP20012466B true GEP20012466B (en) 2001-06-25

Family

ID=20058087

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19932466A GEP20012466B (en) 1992-07-13 1993-07-13 Lysozyme Dimer and Compositions Containing the Same

Country Status (31)

Country Link
US (1) US6132715A (https=)
EP (1) EP0651654B1 (https=)
JP (1) JPH07508744A (https=)
KR (1) KR100289841B1 (https=)
CN (1) CN1057937C (https=)
AT (1) ATE252392T1 (https=)
AU (1) AU677786B2 (https=)
BG (1) BG63331B1 (https=)
BR (1) BR9306722A (https=)
CA (1) CA2140140A1 (https=)
CZ (1) CZ286725B6 (https=)
DE (2) DE69333258T2 (https=)
DK (1) DK0651654T3 (https=)
ES (1) ES2074037T3 (https=)
FI (1) FI950144A0 (https=)
GE (1) GEP20012466B (https=)
GR (1) GR950300039T1 (https=)
HU (1) HU218151B (https=)
MX (1) MX9304197A (https=)
NZ (2) NZ254135A (https=)
OA (1) OA10125A (https=)
PL (1) PL173978B1 (https=)
PT (1) PT651654E (https=)
RO (1) RO112580B1 (https=)
RU (1) RU2145875C1 (https=)
SG (1) SG52727A1 (https=)
SK (1) SK282377B6 (https=)
TW (1) TW259710B (https=)
UA (1) UA49789C2 (https=)
WO (1) WO1994001127A1 (https=)
ZA (1) ZA935046B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
AU5884096A (en) * 1995-05-30 1996-12-18 Lectin Biopharma, Inc. Method of using lectins for agglutination and collection of menstrual flow
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
ITMI981148A1 (it) * 1998-05-22 1999-11-22 Therapicon Srl Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
EP1174147A1 (en) * 2000-06-27 2002-01-23 Nika Health Products Limited Reversal of antibiotic resistance with lysozyme dimer
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
RU2320367C1 (ru) * 2006-08-22 2008-03-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУ ДПО РМАПО Росздрава) Способ сопроводительного лечения острого лимфобластного лейкоза
RU2351351C1 (ru) * 2007-08-08 2009-04-10 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) Средство, повышающее неспецифическую сопротивляемость организма к бактериальным эндотоксинам
RU2472467C2 (ru) * 2011-04-13 2013-01-20 Государственное научное учреждение Краснодарский научно-исследовательский ветеринарный институт (ГНУ КНИВИ) Способ профилактики и лечения гастроэнтеритов, обусловленных бактериозами, у телят
CN105106626A (zh) * 2015-09-30 2015-12-02 成都倍加特生物科技有限公司 一种治疗月经期感染的汤剂药物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4020M (https=) * 1965-01-29 1966-03-21
FR2215201A1 (en) * 1973-01-24 1974-08-23 Theranol Lab Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5533409A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Carcinostatic agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
AU3765689A (en) * 1988-05-31 1990-01-05 Napp Systems (U.S.A.) Inc. Apparatus and process for processing printing plates
KR920702621A (ko) * 1989-06-13 1992-10-06 스튜어트 알. 슈터 단핵세포 및/또는 마크로파지에 의한 인터루킨-1 또는 종양회사인자 생성의 억제
HU214509B (hu) * 1990-01-08 1998-03-30 Nika Health Products Ltd. Eljárás tisztított lizozim dimerek előállítására
US5314816A (en) * 1990-01-08 1994-05-24 Nika Health Products Ltd. Method of preparing lysozyme dimers
WO1992002220A1 (en) * 1990-08-03 1992-02-20 Smithkline Beecham Corporation Tnf inhibitors

Also Published As

Publication number Publication date
SG52727A1 (en) 1998-09-28
CZ8595A3 (en) 1995-09-13
DE69333258T2 (de) 2004-08-26
JPH07508744A (ja) 1995-09-28
EP0651654B1 (en) 2003-10-22
ES2074037T3 (es) 2004-07-01
AU677786B2 (en) 1997-05-08
HUT70973A (en) 1995-11-28
CN1087278A (zh) 1994-06-01
TW259710B (https=) 1995-10-11
MX9304197A (es) 1994-02-28
WO1994001127A1 (en) 1994-01-20
FI950144L (fi) 1995-01-12
HU218151B (hu) 2000-06-28
HU9500098D0 (en) 1995-03-28
ATE252392T1 (de) 2003-11-15
ES2074037T1 (es) 1995-09-01
SK282377B6 (sk) 2002-01-07
BG63331B1 (bg) 2001-10-31
PL173978B1 (pl) 1998-05-29
US6132715A (en) 2000-10-17
CZ286725B6 (en) 2000-06-14
DE69333258D1 (de) 2003-11-27
ZA935046B (en) 1994-02-07
DE651654T1 (de) 1996-01-04
KR100289841B1 (ko) 2001-05-15
OA10125A (en) 1996-12-18
RU2145875C1 (ru) 2000-02-27
UA49789C2 (uk) 2002-10-15
KR950702432A (ko) 1995-07-29
PT651654E (pt) 2004-03-31
BG99287A (bg) 1995-08-28
FI950144A7 (fi) 1995-01-12
NZ254135A (en) 1996-11-26
GR950300039T1 (en) 1995-07-31
DK0651654T3 (da) 2004-02-23
EP0651654A1 (en) 1995-05-10
RO112580B1 (ro) 1997-11-28
CN1057937C (zh) 2000-11-01
NZ299377A (en) 2001-02-23
FI950144A0 (fi) 1995-01-12
SK4095A3 (en) 1995-09-13
AU4568693A (en) 1994-01-31
BR9306722A (pt) 1998-12-08
CA2140140A1 (en) 1994-01-20
PL295273A1 (en) 1994-01-24

Similar Documents

Publication Publication Date Title
IL109634A (en) Peptide derivatives their preparation and pharmaceutical compositions containing them
AU704393C (en) Methods for administration of taxol
EP0550807A3 (en) Use of preparations of curcuma plants
AU3428393A (en) Use of polyamines as ionic-channel regulating agents
AU3073792A (en) Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
IL107587A0 (en) Farnesyl derivatives and pharmaceutical compositions containing them
AU4997093A (en) Treatment of alzheimer's disease and modulation of immune system with delta5-androstenes
EG20279A (en) New derivatives of 3 arylpyrazoles used as fungicides
ZA896673B (en) Biocide compositions
IL103510A0 (en) Pharmaceutical compositions containing antibodies for causing immunosuppression
GEP20012466B (en) Lysozyme Dimer and Compositions Containing the Same
AU4408593A (en) Methods and activator compositions to disinfect lenses
IL98156A0 (en) Pharmaceutical compositions containing magnesium-pyridoxal-5'-phosphate-glutaminate
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
HUT64389A (en) Bleachnig composition containing peroxide
TW287942B (https=)
GR3024283T3 (en) Vector for therapeutic or cosmetic drugs for external use and therapeutic or cosmetic composition containing such a vector
EP0667139A4 (en) DEVICE IMPROVING THE WORKING CAPACITY OF AN INDIVIDUAL: "KUZNETSOV APPLICATOR".
AU4532893A (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
AU3200393A (en) Body tissue omega-3 fatty-acid-augmenting agent and nutrient composition containing the same
HUT70424A (en) Disulfonyl methane derivatives against parasites and pharmaceutical compositions containing such compounds
AU8927191A (en) Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
AU7464994A (en) Beneficial effects of plant volatile oils
SG48900A1 (en) Use of ferrocene
EP0512744A3 (en) Hair treatment composition containing a perfluoropolyether compound and a pearlescing agent